{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:13Z","timestamp":1791576133568,"version":"4.3.4"},"reference-count":50,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,21]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for hematologic malignancies. The primary nonrelapse complication after allo-HSCT is graft-versus-host disease (GVHD). The use of regulatory T cells to prevent GVHD has emerged as a promising allogeneic T-cell immunotherapy in the form of Orca-T. However, the precise differences in immune activation, which may influence infection, GVHD, and relapse after Orca-T compared with unmanipulated peripheral blood stem cell (PBSC) grafts, remain unexplored. Using peripheral blood specimens longitudinally collected between 3 weeks and 1 year after leukemia treatment, we report single-cell RNA sequencing (scRNA-seq) and flow cytometric analysis of 51 HLA-matched patients receiving either Orca-T or unmanipulated PBSC grafts. Orca-T recipients exhibited increased frequencies of effector memory CD4+ T cells 3 weeks after transplantation, and this difference persisted through 6 months after treatment. scRNA-seq analysis 3 weeks after transplantation identified increased expression of FOXP3 and Helios among CD4+CD25\u2212 T conventional cells (Tcon) in Orca-T\u2013treated patients. Using flow cytometry, we then confirmed the increased frequency of this novel population of CD4+CD25\u2212FOXP3+Helios+ Tcon 3 weeks after treatment in patients receiving Orca-T. Furthermore, we discovered that this T-cell subset possessed a regulatory-like phenotype and correlated significantly with the frequencies of activated CD4+ and CD8+ T-cell populations 3 months after treatment, regardless of which therapy patients received. Overall, this study identifies a novel T-cell subset that is enriched very early after cellular therapy for leukemia and may be predictive of long-term immune activation after Orca-T and PBSC-derived T-cell infusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031545","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:54:36Z","timestamp":1772218476000},"page":"2489-2502","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Regulatory-like FOXP3+Helios+CD4+ T conventional cells correlate with T-cell activation after Orca-T immunotherapy"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-0113","authenticated-orcid":false,"given":"Cameron S.","family":"Bader","sequence":"first","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Killian","sequence":"additional","affiliation":[{"name":"2Orca Biosystems, Inc, Menlo Park, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina P.","family":"Iliopoulou","sequence":"additional","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-I","family":"Chen","sequence":"additional","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Pathak","sequence":"additional","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine T.","family":"Le","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-3267","authenticated-orcid":false,"given":"Alejandro","family":"Villar-Prados","sequence":"additional","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhuai","family":"Ji","sequence":"additional","affiliation":[{"name":"4Department of Medicine, Human Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent P.","family":"Jensen","sequence":"additional","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"},{"name":"5Cellular Immune Tolerance Program, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Negrin","sequence":"additional","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"},{"name":"5Cellular Immune Tolerance Program, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everett H.","family":"Meyer","sequence":"additional","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA"},{"name":"5Cellular Immune Tolerance Program, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2026052111220351900_bib1","first-page":"e177","article-title":"Current use and outcome of hematopoietic stem cell transplantation in the United States","volume":"26","author":"Bolon","year":"2022","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"2026052111220351900_bib2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"2026052111220351900_bib3","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"2026052111220351900_bib4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"issue":"9","key":"2026052111220351900_bib5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"issue":"10","key":"2026052111220351900_bib6","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2026052111220351900_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"issue":"4","key":"2026052111220351900_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/bbmt.2003.50027","article-title":"Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response","volume":"9","author":"Jones","year":"2003","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"2026052111220351900_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.beha.2011.05.005","article-title":"Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation","volume":"24","author":"Di Ianni","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"issue":"8","key":"2026052111220351900_bib10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"issue":"86","key":"2026052111220351900_bib11","doi-asserted-by":"crossref","first-page":"35611","DOI":"10.18632\/oncotarget.26242","article-title":"Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution","volume":"9","author":"Kellner","year":"2018","journal-title":"Oncotarget"},{"issue":"14","key":"2026052111220351900_bib12","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2026052111220351900_bib13","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/s41375-023-01932-x","article-title":"A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect","volume":"37","author":"Guardalupi","year":"2023","journal-title":"Leukemia"},{"issue":"4","key":"2026052111220351900_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"issue":"10","key":"2026052111220351900_bib15","doi-asserted-by":"crossref","first-page":"e127244","DOI":"10.1172\/jci.insight.127244","article-title":"Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients","volume":"4","author":"Meyer","year":"2019","journal-title":"JCI Insight"},{"issue":"5","key":"2026052111220351900_bib16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/bloodadvances.2023011625","article-title":"Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD","volume":"8","author":"Bader","year":"2024","journal-title":"Blood Adv"},{"issue":"18","key":"2026052111220351900_bib17","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.2024026446","article-title":"Donor Regulatory T-cell therapy to prevent graft-versus-host disease","volume":"145","author":"Meyer","year":"2025","journal-title":"Blood"},{"issue":"11","key":"2026052111220351900_bib18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood.2025031313","article-title":"Orca-T vs allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial","volume":"147","author":"Meyer","year":"2026","journal-title":"Blood"},{"issue":"2","key":"2026052111220351900_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"issue":"16","key":"2026052111220351900_bib20","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1182\/bloodadvances.2019001032","article-title":"Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD","volume":"4","author":"Latis","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"2026052111220351900_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbmt.2014.01.002","article-title":"Immune cell subset counts associated with graft-versus-host disease","volume":"20","author":"Podgorny","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"2026052111220351900_bib22","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI41072","article-title":"Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation","volume":"120","author":"Matsuoka","year":"2010","journal-title":"J Clin Invest"},{"key":"2026052111220351900_bib23","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3389\/fimmu.2018.01672","article-title":"Mass cytometry for the assessment of immune reconstitution after hematopoietic stem cell transplantation","volume":"9","author":"Stern","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"2026052111220351900_bib24","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41587-023-01685-z","article-title":"Microfluidics-free single-cell genomics with templated emulsification","volume":"41","author":"Clark","year":"2023","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2026052111220351900_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"2026052111220351900_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"2026052111220351900_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12688\/f1000research.22139.1","article-title":"scRepertoire: an R-based toolkit for single-cell immune receptor analysis","volume":"9","author":"Borcherding","year":"2020","journal-title":"F1000Res"},{"issue":"12","key":"2026052111220351900_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"12","key":"2026052111220351900_bib29","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics"},{"key":"2026052111220351900_bib30","doi-asserted-by":"publisher","DOI":"10.1101\/060012","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"1  2021","journal-title":"bioRxiv"},{"issue":"4","key":"2026052111220351900_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"11","key":"2026052111220351900_bib32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41592-021-01282-5","article-title":"Single-cell chromatin state analysis with Signac","volume":"18","author":"Stuart","year":"2021","journal-title":"Nat Methods"},{"issue":"4","key":"2026052111220351900_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"issue":"7-8","key":"2026052111220351900_bib34","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.molimm.2010.02.001","article-title":"A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells","volume":"47","author":"Getnet","year":"2010","journal-title":"Mol Immunol"},{"issue":"6","key":"2026052111220351900_bib35","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood.V75.6.1370.1370","article-title":"Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial","volume":"75","author":"Wagner","year":"1990","journal-title":"Blood"},{"issue":"17","key":"2026052111220351900_bib36","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"2026052111220351900_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3389\/fimmu.2017.01289","article-title":"PD-1 controls tonic signaling and lymphopenia-induced proliferation of T lymphocytes","volume":"8","author":"Ellestad","year":"2017","journal-title":"Front Immunol"},{"issue":"14","key":"2026052111220351900_bib38","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1182\/bloodadvances.2022007735","article-title":"Selected memory T cells infused post-haploidentical hematopoietic stem cell transplantation persist and hyperexpand","volume":"7","author":"van Beek","year":"2023","journal-title":"Blood Adv"},{"issue":"13","key":"2026052111220351900_bib39","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.2023021815","article-title":"The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature","volume":"143","author":"Mathioudaki","year":"2024","journal-title":"Blood"},{"issue":"81","key":"2026052111220351900_bib40","doi-asserted-by":"crossref","first-page":"eabn6429","DOI":"10.1126\/sciimmunol.abn6429","article-title":"Single-cell dissection of human hematopoietic reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Huo","year":"2023","journal-title":"Sci Immunol"},{"key":"2026052111220351900_bib41","doi-asserted-by":"crossref","first-page":"1114368","DOI":"10.3389\/fimmu.2023.1114368","article-title":"Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Obermayer","year":"2023","journal-title":"Front Immunol"},{"key":"2026052111220351900_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/978-1-4419-1599-3_3","article-title":"Molecular regulation of cellular immunity by FOXP3","volume":"665","author":"McMurchy","year":"2009","journal-title":"Adv Exp Med Biol"},{"issue":"17","key":"2026052111220351900_bib43","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1073\/pnas.0509484103","article-title":"Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development","volume":"103","author":"Gavin","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2026052111220351900_bib44","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2012-05-431023","article-title":"A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells","volume":"121","author":"McMurchy","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2026052111220351900_bib45","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4049\/jimmunol.0800216","article-title":"FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression","volume":"183","author":"Torgerson","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"2026052111220351900_bib46","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1073\/pnas.0408679102","article-title":"Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion","volume":"102","author":"Zelenay","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2026052111220351900_bib47","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.176.8.4748","article-title":"Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells","volume":"176","author":"Ono","year":"2006","journal-title":"J Immunol"},{"issue":"727","key":"2026052111220351900_bib48","doi-asserted-by":"crossref","first-page":"eadg6822","DOI":"10.1126\/scitranslmed.adg6822","article-title":"Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations","volume":"15","author":"Borna","year":"2023","journal-title":"Sci Transl Med"},{"issue":"9","key":"2026052111220351900_bib49","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/eji.200737594","article-title":"DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells","volume":"37","author":"Baron","year":"2007","journal-title":"Eur J Immunol"},{"issue":"3","key":"2026052111220351900_bib50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/intimm\/dxn002","article-title":"STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells","volume":"20","author":"Passerini","year":"2008","journal-title":"Int Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/21\/2489\/2521261\/blood_bld-2025-031545-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/21\/2489\/2521261\/blood_bld-2025-031545-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:22:12Z","timestamp":1779376932000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/21\/2489\/566874\/Regulatory-like-FOXP3-Helios-CD4-T-conventional"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":50,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,5,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031545","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,21]]},"published":{"date-parts":[[2026,5,21]]}}}